Belite Bio (BLTE) Total Current Liabilities (2021 - 2025)
Belite Bio (BLTE) posted quarterly Total Current Liabilities of $9.9 million for Q4 2025, up 63.34% year-over-year from $6.0 million in Q4 2024, and up 22.51% quarter-over-quarter from $8.1 million in Q3 2025.
Belite Bio (BLTE) Total Current Liabilities (2021 - 2025) Analysis & Trends
Belite Bio's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $9.9 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 63.34% year-over-year to $9.9 million; the TTM figure through Dec 2025 stood at $9.9 million (up 63.34% YoY), while the FY2025 annual figure was $9.9 million, up 63.34% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $9.9 million, up from $8.1 million in the prior quarter.
- The five-year high for Total Current Liabilities was $9.9 million in Q4 2025, with the low at $1.6 million in Q4 2021.
- The 5-year median for Total Current Liabilities is $4.8 million (2023), against an average of $5.2 million.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities climbed 28.69% in 2022, then jumped 72.67% in 2023.
- Belite Bio's Total Current Liabilities stood at $1.6 million in 2021, then gained by 28.69% to $2.1 million in 2022, then surged by 72.67% to $3.6 million in 2023, then soared by 66.53% to $6.0 million in 2024, then surged by 63.34% to $9.9 million in 2025.
- Business Quant data shows BLTE's Total Current Liabilities at $9.9 million in Q4 2025, $8.1 million in Q3 2025, and $6.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.88 Mn |
| Sep 30, 2025 | 8.07 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Dec 31, 2023 | 3.63 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 1.64 Mn |